Skip to content

Dual antiplatelet therapy contains rivaroxaban in advanced age patients with Atrial Fibrillation and Acute Coronary Syndromes without revascularization

Dual antiplatelet therapy contains rivaroxaban in advanced age patients with Atrial Fibrillation and Acute Coronary Syndromes without revascularization

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014852
Enrollment
Unknown
Registered
2018-02-09
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

Group 3:clopidogrel plus rivaroxaban
Group 1:aspine plus clopidogrel
Group 2:aspine plus rivaroxaban

Sponsors

Tianjin Union Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged =75 years old; 2. Persistent non-valvular atrial fibrillation; 3. unstable angina or Non-st elevation myocardial infarction; 4. without revascularization patients.

Exclusion criteria

Exclusion criteria: (1) the history of hematopathy; (2) unexplained fever (> 37. 5 ?) or severe infection; (3) unbalanced electrolyte and acid-base imbalance; (4) severe liver and renal insufficiency; (5) patients with active infectious diseases; (6) severe cerebrovascular disease cannot be combined with treatment; (7) allergic to aspirin, clopidogrel and rivaroxaban; (8) surgery history or trauma history within 1 month; (9) the international standardized rate (INR)>2.5 in the treatment of hemorrhage or warfarin; (10) significant aortic valve insufficiency; (11) merge aortic dissection; (12) pregnant swomen and patients with mental illness; (13) emergency or elective coronary artery bypass grafting; (14) patients with previous myocardial infarction.

Design outcomes

Primary

MeasureTime frame
left ventricular ejection fraction;Estimate pulmonary artery pressure;Load cardiac ultrasound;six-minutes walking test;NT-ProBNP;D-dimer;inflammatory factor;oxidative stress;Coagulation related indicators;

Countries

China

Contacts

Public ContactPANG ZHIHUA

Tianjin Union Medical Center

HZ1126@126.com+86 13502192078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026